| 000 | 01707 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515185813.0 | ||
| 264 | 0 | _c20100301 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1098-2396 | ||
| 024 | 7 |
_a10.1002/syn.20709 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuck, Kerstin | |
| 245 | 0 | 0 |
_aThe selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bSynapse (New York, N.Y.) _cFeb 2010 |
||
| 300 |
_a117-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdrenergic alpha-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacokinetics |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCerebrospinal Fluid _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
| 650 | 0 | 4 |
_aIdazoxan _xpharmacology |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 | _aOxidopamine |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
| 650 | 0 | 4 |
_aPlasma _xmetabolism |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xmetabolism |
| 650 | 0 | 4 |
_aTetralones _xpharmacokinetics |
| 700 | 1 | _aFerger, Boris | |
| 773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 64 _gno. 2 _gp. 117-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/syn.20709 _zAvailable from publisher's website |
| 999 |
_c19168673 _d19168673 |
||